Inactive Instrument

Highlights Celladon Corp Nasdaq

Equities

US15117E1073

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Eiger BioPharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 08	CI
News Highlights : Top Company News of the Day - Tuesday at 1 AM ET	Apr. 02	DJ
News Highlights : Top Company News of the Day - Monday at 9 PM ET	Apr. 01	DJ
Health Care Down as Obesity-Drug Optimism Fades -- Health Care Roundup	Apr. 01	DJ
News Highlights : Top Company News of the Day - Monday at 5 PM ET	Apr. 01	DJ
Sector Update: Health Care Stocks Slide Late Afternoon	Apr. 01	MT
News Highlights : Top Company News of the Day - Monday at 3 PM ET	Apr. 01	DJ
Sector Update: Health Care	Apr. 01	MT
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection; Shares Fall	Apr. 01	MT
Eiger BioPharmaceuticals Gets Marketing Approval for Treatment of Ultra-Rare Genetic Disease	Jan. 19	MT
Eiger BioPharmaceuticals, Inc. and Partner, AnGes, Inc. Receive Approval for Zokinvy for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan	Jan. 18	CI
Eiger BioPharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Earnings Flash (EIGR) EIGER BIOPHARMACEUTICALS Posts Q3 Revenue $3.2M	Nov. 09	MT
Eiger to discontinue hepatitis drug study over safety concerns	23-09-12	RE
Eiger to discontinue hepatitis drug study	23-09-12	RE
Eiger BioPharmaceuticals, Inc. Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta	23-09-12	CI
North American Morning Briefing : Treasury Yields Keep Pushing Higher	23-08-17	DJ
Earnings Flash (EIGR) EIGER BIOPHARMACEUTICALS Posts Q2 Revenue $4.6M	23-08-14	MT
Eiger BioPharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Eiger Biopharmaceuticals to Focus on Metabolic Diseases with Avexitide	23-06-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Celladon Corp Nasdaq

Equities

US15117E1073

Highlights

Filters